Quality of Life 1y and 2 y After VV-ECMO for COVID-19

Ghent University Hospital (UZ)

Status: Completed

Conditions: Death; Quality of Life; Extracorporeal Membrane Oxygenation Complication; COVID-19 Acute Respiratory Distress Syndrome

Treatments: Device: VV-ECMO

Study type: Observational

Funder types: Other

Identifiers

NCT05780255

COVID-19-ECMO BC-09806

Details and patient eligibility

About

This study aims to investigate the quality of life and the outcome after veno-venous extracoporeal membrane oxygenation (ECMO) support fir severe acute respiratory syndrome (ARDS) in COVID-19 patients.

Full description

The investigators follow our COVID-19 patients supported by ECMO, we make phone calls or real-life visits to pthe patients to score the quality of life, by using the SF-36. The SF-36 measures eight scales: physical functioning, role physical, bodily pain, general health, vitality , social functioning , role emotional , and mental health.

The participants are contacted 3 months, 6months, 1year and 2 years after the ECMO support started for evaluation of the SF-36.

Enrollment: 28 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with PCR-confirmed COVID-19 infection AND
• Acute Respiratory Distress Syndrome who require veno-venous ECMO therapy.

Exclusion criteria

• None

Trial design

28 participants in 1 patient group

COVID-19 positive patients

Description:

Patients with a PCR-confirmed COVID-19 infection, with ARDS and supported by VV-ECMO

Treatment:

Device: VV-ECMO